Form D · Pharmaceuticals

Synspira, LLC

Cambridge, MA · CIK 0001716536

Offering snapshot reported Sep 15, 2017 · SEC filing

Reported sold
$8.24M
Offering amount: $8.24M
Investors reported
4
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Aug 30, 2017
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$4.12M$8.24MSep 12, 2017: $3,240,142.00Sep 12, 2017Sep 15, 2017: $8,240,942.00Sep 15, 2017

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$3,240,142 → $8,240,942

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Sep 15, 2017Amendment$8,240,942$5,000,800vs Sep 12, 20174SEC filing
Sep 12, 2017Initial$3,240,142No comparison4SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-294475

Source: Form D, filed Sep 15, 2017. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Shenda Baker Director, Executive
Glenn Batchelder Director
William P. Wiesmann, M.D. Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
One Broadway, Suite 1400
Cambridge, MA, 02142